Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Market Reports & Share Ideas
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Market Reports & Share Ideas
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
- Advertisement -
Tags
Destiny Pharma
Tag:
Destiny Pharma
Shares
AIM movers: Golden Metal Resources progresses survey work and Deltic Energy fails to find partner
Andrew Hore
-
11/06/2024
0
Shares
AIM movers: Merit profit recovery and ex-dividends
Andrew Hore
-
25/04/2024
0
Shares
AIM movers: Angle DNA breakthrough and ex-dividends
Andrew Hore
-
04/01/2024
5
Shares
AIM movers: Shoe Zone beats expectations again and i-nexus Global loses client
Andrew Hore
-
17/10/2023
1
Shares
AIM movers: Mercantile Ports contract and ex-dividends
Andrew Hore
-
25/05/2023
0
Shares
AIM weekly movers: Destiny Pharma secures partner but discounted placing hits share price
Andrew Hore
-
24/02/2023
10
Shares
AIM movers: Tekmar contract and ex-dividends
Andrew Hore
-
22/12/2022
5
Premium
Tip update: Disappointing Destiny still has potential
Andrew Hore
-
20/03/2022
2
Premium
Tip update: Long-term prospects still huge for Destiny Pharma
Andrew Hore
-
12/09/2021
0
Premium
TIP: The AIM share preventing hospital infections
Andrew Hore
-
06/06/2021
0
1
2
3
Page 2 of 3
Most Read
AIM movers: Restore upgrade and ex-dividends
12/03/2026
FTSE 100 falls after oil briefly trades above $100
12/03/2026
Margins improve at James Fisher
12/03/2026
SigmaRoc: Finals due next Monday will be impressive, shares 128p, on 11.3 times current year earnings, TP 216p
12/03/2026